Correlation Between Medicofarma Biotech and MLP Group

Can any of the company-specific risk be diversified away by investing in both Medicofarma Biotech and MLP Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medicofarma Biotech and MLP Group into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Medicofarma Biotech SA and MLP Group SA, you can compare the effects of market volatilities on Medicofarma Biotech and MLP Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medicofarma Biotech with a short position of MLP Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medicofarma Biotech and MLP Group.

Diversification Opportunities for Medicofarma Biotech and MLP Group

0.64

Correlation Coefficient

Medicofarma Biotech  MLP Group

Poor diversification

The 3 months correlation between Medicofarma and MLP is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Medicofarma Biotech SA and MLP Group SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MLP Group SA and Medicofarma Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medicofarma Biotech SA are associated (or correlated) with MLP Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MLP Group SA has no effect on the direction of Medicofarma Biotech i.e., Medicofarma Biotech and MLP Group go up and down completely randomly.

Pair Corralation between Medicofarma Biotech and MLP Group

Assuming the 90 days trading horizon Medicofarma Biotech SA is expected to generate 1.55 times more return on investment than MLP Group. However, Medicofarma Biotech is 1.55 times more volatile than MLP Group SA. It trades about -0.05 of its potential returns per unit of risk. MLP Group SA is currently generating about -0.12 per unit of risk. If you would invest  52.00  in Medicofarma Biotech SA on October 11, 2024 and sell it today you would lose (10.00) from holding Medicofarma Biotech SA or give up 19.23% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	98.25%
Values	Daily Returns

Medicofarma Biotech SA  vs.  MLP Group SA

Medicofarma Biotech

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Medicofarma Biotech SA has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in February 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

MLP Group SA

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days MLP Group SA has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in February 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Pair Trading with Medicofarma Biotech and MLP Group

The main advantage of trading using opposite Medicofarma Biotech and MLP Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medicofarma Biotech position performs unexpectedly, MLP Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MLP Group will offset losses from the drop in MLP Group's long position.

The idea behind Medicofarma Biotech SA and MLP Group SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.